Correlation Between AdvisorShares Pure and AdvisorShares Vice
Can any of the company-specific risk be diversified away by investing in both AdvisorShares Pure and AdvisorShares Vice at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AdvisorShares Pure and AdvisorShares Vice into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AdvisorShares Pure Cannabis and AdvisorShares Vice ETF, you can compare the effects of market volatilities on AdvisorShares Pure and AdvisorShares Vice and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AdvisorShares Pure with a short position of AdvisorShares Vice. Check out your portfolio center. Please also check ongoing floating volatility patterns of AdvisorShares Pure and AdvisorShares Vice.
Diversification Opportunities for AdvisorShares Pure and AdvisorShares Vice
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AdvisorShares and AdvisorShares is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding AdvisorShares Pure Cannabis and AdvisorShares Vice ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AdvisorShares Vice ETF and AdvisorShares Pure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AdvisorShares Pure Cannabis are associated (or correlated) with AdvisorShares Vice. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AdvisorShares Vice ETF has no effect on the direction of AdvisorShares Pure i.e., AdvisorShares Pure and AdvisorShares Vice go up and down completely randomly.
Pair Corralation between AdvisorShares Pure and AdvisorShares Vice
Given the investment horizon of 90 days AdvisorShares Pure Cannabis is expected to generate 5.57 times more return on investment than AdvisorShares Vice. However, AdvisorShares Pure is 5.57 times more volatile than AdvisorShares Vice ETF. It trades about 0.01 of its potential returns per unit of risk. AdvisorShares Vice ETF is currently generating about 0.06 per unit of risk. If you would invest 540.00 in AdvisorShares Pure Cannabis on August 26, 2024 and sell it today you would lose (95.00) from holding AdvisorShares Pure Cannabis or give up 17.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AdvisorShares Pure Cannabis vs. AdvisorShares Vice ETF
Performance |
| Timeline |
| AdvisorShares Pure |
| AdvisorShares Vice ETF |
AdvisorShares Pure and AdvisorShares Vice Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AdvisorShares Pure and AdvisorShares Vice
The main advantage of trading using opposite AdvisorShares Pure and AdvisorShares Vice positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AdvisorShares Pure position performs unexpectedly, AdvisorShares Vice can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AdvisorShares Vice will offset losses from the drop in AdvisorShares Vice's long position.| AdvisorShares Pure vs. SPDR Kensho New | AdvisorShares Pure vs. Global X FinTech | AdvisorShares Pure vs. iShares Genomics Immunology | AdvisorShares Pure vs. Aquagold International |
| AdvisorShares Vice vs. SPDR Kensho New | AdvisorShares Vice vs. Global X FinTech | AdvisorShares Vice vs. iShares Genomics Immunology | AdvisorShares Vice vs. Aquagold International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |